AA
ES
Operational performance in 2021

Operational performance in 2021

The fiscal year-end results can be described as very positive, the main income statement figures having grown despite the fact that there were no COVID-19 impacts until March of the previous year.
Economic sales (€M)
634
TOTAL
VAR.
6.9%
303
Tobacco and related products
3.5%
291
Transport
6.9%
83
Pharmaceutical distribution
20.1%
17
Other businesses
0.8%
(60)
Adjustments
(4.2)%
Adjusted EBIT (€M)
134
VAR.
19.3%

IBERIA

  • Tobacco and related products: Good performance, mainly due to the value-added services billed to tobacco manufacturers, which helped to offset the slight fall in tobacco volumes distributed, and the Economic Sales of convenience products distributed growth at a double-digit rate compared with 2020, explained by the influx of new customers, the rise in point-of-sale customers and the increasing demand for convenience products in these stores.
  • Transport: The situation caused by the pandemic favoured an increase in electronic commerce leading to a significant uplift in the parcel services business, while mobility restrictions and selective lockdowns brought down demand in the industrial parcel sector. However, pre-pandemic sales levels were recovered towards the end of the year as the industrial parcel business bounced back.
    Long-distance transport sales improved over the course of the year, due partly to the addition and expansion of transport services for the pharmaceutical industry and the high-tech, mass consumption and fruit sectors, and to the rebound in tobacco volumes.
  • Pharmaceutical distribution: Good performance thanks to a steady influx of customers and the launch of new dedicated services for the industry, targeting both existing and new customers.
    The circumstances during the pandemic gave rise to changing needs in the pharmaceutical and healthcare sectors that are being answered by Logista Pharma, such as the management of clinical trials, direct delivery of medicines to hospital patients and supply of critical medicines for COVID-19. This boosted business thanks to new customer profiles, such as public authorities and hospitals, as well as new products such as COVID-19 vaccines and healthcare and protection materials.
  • Other Businesses: Slightly stable performance despite the difficult situation in the industry.
Economic sales (€M)
325
TOTAL
VAR.
6.5%
325
Tobacco and related products
6.5%
Adjusted EBIT (€M)
99
VAR.
14%

ITALY

The increase in revenue from services provided to manufacturers and from the distribution of convenience products allowed Economic Sales to grow 6.5%.
  • Tobacco and related products: As regards services to manufacturers, the new tobacco product categories in Italy and the value-added services associated with this type of products are performing well.
    Commercial efforts to boost growth in the distribution of convenience products focused this year on the beverages category, new agreements having been reached with manufacturers in this sector, complementing the increase in the snacks and sweets category. As a result, Economic Sales in the distribution of convenience products once again reached double-digit growth.
Economic sales (€M)
225
TOTAL
VAR.
0.2%
225
Tobacco and related products
0.2%
Adjusted EBIT (€M)
66
VAR.
1.4%

FRANCE

Economic Sales rose by 0.2% thanks to growth in the distribution of electronic transactions and convenience products, offsetting the poor Economic Sales in tobacco distribution.
  • Tobacco and related products: The Company decided to classify Supergroup (the Group subsidiary engaged in distributing convenience products to points of sale other than tobacconists in France) as an “available-for-sale” asset at the end of the current fiscal year, so its results are included under discontinued operations and its Revenues, Economic Sales and results are no longer part of the France segment. The Other businesses sub-segment is no longer included in this segment, all the activities in France forming part of the Tobacco and other related products sub-segment. The corresponding figures were restated to reflect this classification and assure comparability between 2021 and 2020.

Before starting...

We use our own and third party cookies for analytical purposes, to show you personalized advertising based on a profile made from your browsing habits (for example, pages visited). Click here for more information. You can accept all cookies by pressing the "Accept" button, configure them, or refuse their use by pressing the "Configure" button.

ACCEPT AND CONTINUE Set cookies